Auna S.A. (AUNA) Q1 Earnings Top Estimates

Auna S.A. (AUNA) reported Q1 earnings of $0.19 per share, surpassing the Zacks Consensus Estimate of $0.10, a 90% surprise; however, revenues of $281.43 million missed estimates by 5.95%. Despite the EPS beat, Auna's revenue fell short of expectations and prior-year figures, and the stock holds a Zacks Rank #3 (Hold), suggesting near-term performance in line with the market, contingent on management's commentary and earnings estimate revisions.

Analysis

Auna S.A. (AUNA) reported mixed Q1 2025 results, characterized by a significant earnings beat but a revenue shortfall. Quarterly earnings per share (EPS) came in at $0.19, substantially exceeding the Zacks Consensus Estimate of $0.10 (a 90% surprise) and improving from $0.10 per share a year ago, marking the second EPS beat in four quarters following a prior -20% earnings surprise. However, revenues of $281.43 million missed the consensus estimate by 5.95% and declined from $286.43 million in the prior-year quarter; the company has topped revenue estimates only once in the last four quarters. Despite these mixed operational results, AUNA's shares have outperformed the S&P 500 year-to-date, gaining approximately 3.2% versus the index's 1.4%. The company currently holds a Zacks Rank #3 (Hold), suggesting expectations of near-term performance in line with the market, though the sustainability of stock momentum hinges significantly on management's upcoming earnings call commentary and subsequent revisions to earnings estimates, which were mixed pre-release. Current consensus forecasts project $0.16 EPS on $314.67 million in revenue for the next quarter, while AUNA's Medical Services industry is favorably ranked in the top 22% of Zacks industries, implying a potentially supportive sector backdrop.

Key Decisions for Investors

• Given Auna's Q1 results showing a strong EPS beat but a concerning revenue miss and year-over-year decline, investors should exercise caution and evaluate the sustainability of earnings momentum.
• Closely scrutinize management's upcoming earnings call commentary for insights into revenue recovery strategies, margin outlook, and the drivers behind the EPS outperformance before adjusting positions, especially considering the historical inconsistency in meeting estimates.
• While the stock has outperformed year-to-date and belongs to a favorably ranked industry, the Zacks Rank #3 (Hold) and mixed prior estimate revisions warrant monitoring future estimate changes to assess if the current earnings strength is sustainable against the backdrop of revenue challenges.